Skip to main content
SpringerLink
Log in

Obstructive Sleep Apnea in Children

Do Intranasal Corticosteroids Help?

  • Current Opinion
  • Published:
American Journal of Respiratory Medicine

Abstract

Obstructive sleep apnea (OSA) is a common condition of childhood, and is associated with significant morbidity. Prevalence of the condition peaks during early childhood, due in part to adenoidal and tonsillar enlargement within a small pharyngeal space. The lymphoid tissues regress after 10 years of age, in the context of ongoing bony growth, and there is an associated fall in the prevalence of OSA. Obstruction of the nasopharynx by adenoidal enlargement promotes pharyngeal airway collapse during sleep, and the presence of large tonsils contributes to airway obstruction. Administration of systemic corticosteroids leads to a reduction in the size of lymphoid tissues due to anti-inflammatory and lympholytic effects. However, a short course of systemic prednisone has been demonstrated not to have a significant effect on adenoidal size or the severity of OSA, and adverse effects preclude the long-term use of this therapy. Intranasal corticosteroids are effective in relieving nasal obstruction in allergic rhinitis, and allergic sensitization is more prevalent among children who snore than among those who do not snore. Intranasal corticosteroids have also been demonstrated to reduce adenoidal size, independent of the individual’s atopic status. There is preliminary evidence of an improvement in the severity of OSA in children treated with intranasal corticosteroids, but further studies are needed before such therapy can be routinely recommended. Prescribing clinicians should take into account the potential benefits to the patient, the age of the child, the presence of comorbidities such as allergic rhinitis, the agent used, and the dose and duration of treatment when considering such therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Table I
Fig. 4

Similar content being viewed by others

References

  1. Gislason T, Benediktsdottir B. Snoring, apneic episodes, and nocturnal hypoxemia among children 6 months to 6 years old: an epidemiologic study of lower limit of prevalence. Chest 1995; 107(4): 963–6

    Article  PubMed  CAS  Google Scholar 

  2. Ali NJ, Pitson DJ, Stradling JR. Snoring, sleep disturbance, and behaviour in 4-5 year olds. Arch Dis Child 1993; 68(3): 360–6

    Article  PubMed  CAS  Google Scholar 

  3. Redline S, Tishler PV, Schluchter M, et al. Risk factors for sleep-disordered breathing in children. Associations with obesity, race, and respiratory symptoms. Am J Respir Crit Care Med 1999; 159: 1527–32

    PubMed  CAS  Google Scholar 

  4. Anuntaseree W, Rookkapan K, Kuasirikul S, et al. Snoring and obstructive sleep apnea in Thai school-age children: prevalence and predisposing factors. Pediatr Pulmonol 2001; 32: 222–7

    Article  PubMed  CAS  Google Scholar 

  5. Brunetti L, Rana S, Lospalluti ML, et al. Prevalence of obstructive sleep apnea syndrome in a cohort of 1,207 children of southern Italy. Chest 2001; 120: 1930–5

    Article  PubMed  CAS  Google Scholar 

  6. Gozal D. Sleep-disordered breathing and school performance in children. Pediatrics 1998; 102 (3 Pt 1): 616–20

    Article  PubMed  CAS  Google Scholar 

  7. Brouillette RT, Fernbach SK, Hunt CE. Obstructive sleep apnea in infants and children. J Pediatr 1982; 100(1): 31–40

    Article  PubMed  CAS  Google Scholar 

  8. Fernbach SK, Brouillette RT, Riggs TW, et al. Radiologic evaluation of adenoids and tonsils in children with obstructive sleep apnea: plain films and fluoroscopy. Pediatr Radiol 1983; 13(5): 258–65

    Article  PubMed  CAS  Google Scholar 

  9. Suen JS, Arnold JE, Brooks LJ. Adenotonsillectomy for treatment of obstructive sleep apnea in children. Arch Otolaryngol Head Neck Surg 1995; 121: 525–30

    Article  PubMed  CAS  Google Scholar 

  10. Helfaer MA, McColley SA, Pyzik PL, et al. Polysomnography after adenotonsillectomy in mild pediatric obstructive sleep apnea. Crit Care Med 1996; 24(8): 1323–7

    Article  PubMed  CAS  Google Scholar 

  11. Gerber ME, O’Connor DM, Adler E, et al. Selected risk factors in pediatric adenotonsillectomy. Arch Otolaryngol Head Neck Surg 1996; 122: 811–4

    Article  PubMed  CAS  Google Scholar 

  12. McColley SA, April MM, Carroll JZ, et al. Respiratory compromise after adenotonsillectomy in children with obstructive sleep apnea. Arch Otolaryngol Head Neck Surg 1992; 118: 940–3

    Article  PubMed  CAS  Google Scholar 

  13. Rosen GM, Muckle RP, Mahowald MW, et al. Postoperative respiratory compromise in children with obstructive sleep apnea syndrome: can it be anticipated? Pediatrics 1994; 93(5): 784–8

    PubMed  CAS  Google Scholar 

  14. Wilson K, Lakheeram I, Morielli A, et al. Can assessment for obstructive sleep apnea help predict postadenotonsillectomy respiratory complications? Anesthesiology 2001; 96(2): 313–22

    Article  Google Scholar 

  15. Randall DA, Hoffer ME. Complications of tonsillectomy and adenoidectomy. Otolaryngol Head Neck Surg 1998; 118(1): 61–8

    Article  PubMed  CAS  Google Scholar 

  16. Pratt LW, Gallagher RA. Tonsillectomy and adenoidectomy: incidence and mortality, 1968-1972. Otolaryngol Head Neck Surg 1979; 87(2): 159–66

    PubMed  CAS  Google Scholar 

  17. Hudgel DW, Martin RJ, Johnson B, et al. Mechanics of the respiratory system and breathing pattern during sleep in normal humans. J Appl Physiol 1984; 56: 133–7

    PubMed  CAS  Google Scholar 

  18. Wiegand DA, Zwillich CW, White DP. Collapsibility of the human upper airway during normal sleep. J Appl Physiol 1989; 66: 1800–8

    Article  PubMed  CAS  Google Scholar 

  19. Wiegand DA, Latz B, Zwillich CW, et al. Geniohyoid muscle activity in normal men during wakefulness and sleep. J Appl Physiol 1990; 69(4): 1262–9

    PubMed  CAS  Google Scholar 

  20. Wiegand DA, Latz B, Zwillich CW, et al. Upper airway resistance and geniohyoid muscle activity in normal men during wakefulness and sleep. J Appl Physiol 1990; 69(4): 1252–61

    PubMed  CAS  Google Scholar 

  21. Tangel DJ, Mezzanotte WS, White DP. Influence of sleep on tensor palatini EMG and upper airway resistance in normal men. J Appl Physiol 1991; 70: 2574–81

    PubMed  CAS  Google Scholar 

  22. Remmers JE, deGroot WJ, Sauerland EK, et al. Pathogenesis of upper airway occlusion during sleep. J Appl Physiol 1978; 44(6): 931–8

    PubMed  CAS  Google Scholar 

  23. Marcus CL, McColley SA, Carroll JL, et al. Upper airway collapsibility in children with obstructive sleep apnea syndrome. J Appl Physiol 1994; 77(2): 918–24

    PubMed  CAS  Google Scholar 

  24. Kawashima S, Niikuni N, Chia-hung L, et al. Cephalometric comparisons of craniofacial and upper airway structures in young children with obstructive sleep apnea syndrome. Ear Nose Throat J 2000; 79(7): 499–6

    PubMed  CAS  Google Scholar 

  25. Zucconi M, Caprioglio A, Calori G, et al. Craniofacial modifications in children with habitual snoring and obstructive sleep apnoea: a case-control study. Eur Respir J 1999; 13(2): 411–7

    Article  PubMed  CAS  Google Scholar 

  26. Agren K, Nordlander B, Linder-Aronsson S, et al. Children with nocturnal upper airway obstruction: postoperative orthodontic and respiratory improvement. Acta Otolaryngol 1998; 118(4): 581–7

    Article  PubMed  CAS  Google Scholar 

  27. Vogler RC, Wippold FJ, Pilgram TK. Age-specific size of the normal adenoid pad on magnetic resonance imaging. Clin Otolaryngol 2000; 25: 392–5

    Article  PubMed  CAS  Google Scholar 

  28. Brodsky L. Modern assessment of tonsils and adenoids. Pediatr Clin North Am 1989; 36(6): 1551–69

    PubMed  CAS  Google Scholar 

  29. Fujioka M, Young LW, Girdany BR. Radiographic evaluation of adenoidal size in children: adenoidal-nasopharyngeal ratio. AJR Am J Roentgenol 1979; 133(3): 401–4

    PubMed  CAS  Google Scholar 

  30. Jeans WD, Fernando DC, Maw AR, et al. A longitudinal study of the growth of the nasopharynx and its contents in normal children. Br J Radiol 1981; 54(638): 117–21

    Article  PubMed  CAS  Google Scholar 

  31. Arens R, McDonough JM, Corbin AM, et al. Linear dimensions of the upper airway structure during development. Am J Respir Crit Care Med 2002; 165(1): 117–22

    PubMed  Google Scholar 

  32. Brouillette RT, Morielli A, Leimanis A, et al. Nocturnal pulse oximetry as an abbreviated testing modality for pediatric obstructive sleep apnea. Pediatrics 2000; 105(2): 405–2

    Article  PubMed  CAS  Google Scholar 

  33. Brooks LJ, Stephens BM, Bacevice M. Adenoid size is related to severity but not the number of episodes of obstructive apnea in children. J Pediatr 1998; 132: 682–6

    Article  PubMed  CAS  Google Scholar 

  34. Arens R, McDonough JM, Costarino AT, et al. Magnetic resonance imaging of the upper airway structure of children with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2001; 164: 698–703

    PubMed  CAS  Google Scholar 

  35. Guilleminault C, Pelayo R, Leger D, et al. Recognition of sleep-disordered breathing in children. Pediatrics 1996; 98(5): 871–82

    PubMed  CAS  Google Scholar 

  36. Waters KA, Forbes P, Morielli A, et al. Sleep-disordered breathing in children with myelomeningocele. J Pediatr 1998; 132(4): 672–81

    Article  PubMed  CAS  Google Scholar 

  37. Tasker RC, Dundas I, Laverty A, et al. Distinct patterns of respiratory difficulty in young children with achondroplasia: a clinical, sleep, and lung function study. Arch Dis Child 1998; 79(2): 99–108

    Article  PubMed  CAS  Google Scholar 

  38. Hertz G, Cataletto M, Feinsilver SH, et al. Sleep and breathing patterns in patients with Prader Willi syndrome (PWS): effects of age and gender. Sleep 1993; 16(4): 366–71

    PubMed  CAS  Google Scholar 

  39. Freezer NJ, Bucens IK, Robertson CF. Obstructive sleep apnoea presenting as failure to thrive in infancy. J Paediatr Child Health 1995; 31: 172–5

    Article  PubMed  CAS  Google Scholar 

  40. Marcus CL, Keens TG, Bautista DB, et al. Obstructive sleep apnea in children with Down syndrome. Pediatrics 1991; 88(1): 132–9

    PubMed  CAS  Google Scholar 

  41. Uong EC, McDonough JM, Tayag-Kier CE, et al. Magnetic resonance imaging of the upper airway in children with Down syndrome. Am J Respir Crit Care Med 2001; 163: 731–6

    PubMed  CAS  Google Scholar 

  42. Biavati MJ, Manning SC, Phillips DL. Predictive factors for respiratory complications after adenotonsillectomy and adenoidectomy in children. Arch Otolaryngol Head Neck Surg 1997; 123: 517–21

    Article  PubMed  CAS  Google Scholar 

  43. Mygind N, Nielsen LP, Hoffman H-J, et al. Mode of action of intranasal corticosteroids. J Allergy Clin Immunol 2001; 108: S16–25

    Article  PubMed  CAS  Google Scholar 

  44. Yu DT, Clements PJ, Paulus HE, et al. Human lymphocyte subpopulations. Effect of corticosteroids. J Clin Invest 1974; 53(2): 565–71

    Article  PubMed  CAS  Google Scholar 

  45. Makman MH, Dvorkin B, White A. Evidence for induction by cortisol in vitro of a protein inhibitor of transport and phosphorylation processes in rat thymocytes. Proc Natl Acad Sci U S A 1971; 68(6): 1269–73

    Article  PubMed  CAS  Google Scholar 

  46. Dougherty RF, White A. Functional alterations in lymphoid tissue induced by adrenal cortical secretion. Am J Anat 1945; 77: 81–115

    Article  Google Scholar 

  47. Sudderick RM, Narula AA. Steroids for airway problems in glandular fever. J Laryngol Otol 1987; 101(7): 673–5

    Article  PubMed  CAS  Google Scholar 

  48. Corren J. Intranasal steroids for allergic rhinitis: how do different agents compare? J Allergy Clin Immunol 1999; 104: S144–9

    Article  PubMed  CAS  Google Scholar 

  49. Johnson M. Development of fluticasone propionate and comparison with other inhaled corticosteroids. J Allergy Clin Immunol 1998; 101(4): S434–9

    Article  PubMed  CAS  Google Scholar 

  50. Umland SP, Nahrebne DK, Razac S, et al. The inhibitory effects of topically active glucocorticoids on IL-4, IL- 5, and interferon-gamma production by cultured primary CD4+ T cells. J Allergy Clin Immunol 1997; 100(4): 511–9

    Article  PubMed  CAS  Google Scholar 

  51. RhinocortAqua™ prescribing information. AstraZeneca

  52. Onrust SV, Lamb HM. Mometasone furoate: a review of its intranasal use in allergic rhinitis. Drugs 1998; 56(4): 725–45

    Article  PubMed  CAS  Google Scholar 

  53. Bryson HM, Faulds D. Intranasal fluticasone propionate: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in allergic rhinitis. Drugs 1992; 43(5): 760–75

    Article  PubMed  CAS  Google Scholar 

  54. Boner AL. Effects of intranasal corticosteroids on the hypothalamic-pituitary-adrenal axis in children. J Allergy Clin Immunol 2001; 108: S32–9

    Article  PubMed  CAS  Google Scholar 

  55. Agertoft L, Pedersen S. Short-term lower leg growth rate in children with rhinitis treated with intranasal mometasone furoate and budesonide. J Allergy Clin Immunol 1999; 104: 948–52

    Article  PubMed  CAS  Google Scholar 

  56. Skoner DP, Rachelefsky GS, Meltzer EO, et al. Detection of growth suppression in children during treatment with intranasal beclomethasone dipropionate. Pediatrics 2000; 105(2): E23

    Article  PubMed  CAS  Google Scholar 

  57. Schenkel EJ, Skoner DP, Bronsky EA, et al. Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray. Pediatrics 2000; 105(2): E22

    Article  PubMed  CAS  Google Scholar 

  58. Agertoft L, Pedersen S. Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. N Engl J Med 2000; 343(15): 1064–9

    Article  PubMed  CAS  Google Scholar 

  59. Silverstein MD, Yunginger JW, Reed CE, et al. Attained adult height after childhood asthma: effect of glucocorticoid therapy. J Allergy Clin Immunol 1997; 99(4): 466–74

    Article  PubMed  CAS  Google Scholar 

  60. Allen DB, Mullen M, Mullen B. A meta-analysis of the effect of oral and inhaled corticosteroids on growth. J Allergy Clin Immunol 1994; 93(6): 967–76

    Article  PubMed  CAS  Google Scholar 

  61. Center for Drug Evaluation and Research, Food and Drug Administration, U.S. Department of Health and Human Services. Guidance for industry evaluation of the effects of orally inhaled and intranasal corticosteroid on growth in children [online]. Available from URL: http://www.fda.gov/cder/guidance/3787dft.htm. [Accessed 2001 May 24]

  62. Scadding GK. Corticosteroids in the treatment of pediatric allergic rhinitis. J Allergy Clin Immunol 2001; 108: S59–64

    Article  PubMed  CAS  Google Scholar 

  63. Hynes B, Cole P, Forte V, et al. The evaluation of intranasal topical beclomethasone spray in the treatment of children with non-purulent rhinitis using rhinometric, cytologic and symptomatologic assessment. J Otolaryngol 1989; 18(4): 151–4

    PubMed  CAS  Google Scholar 

  64. Kobayashi RH, Tinkelman DG, Reese ME, et al. Beclomethasone dipropionate aqueous nasal spray for seasonal allergic rhinitis in children. Ann Allergy 1989; 62(3): 205–8

    PubMed  CAS  Google Scholar 

  65. Wolthers OD, Jorgensen BA, Pedersen S. A double-blind, placebo-controlled study of the effect of intranasal budesonide in the treatment of children with seasonal rhinitis. Acta Paediatr 1992; 81(11): 902–6

    Article  PubMed  CAS  Google Scholar 

  66. Day JH, Andersson CB, Briscoe MP. Efficacy and safety of intranasal budesonide in the treatment of perennial rhinitis in adults and children. Ann Allergy 1990; 64(5): 445–50

    PubMed  CAS  Google Scholar 

  67. Todd GB, Neame JH. A study of flunisolide nasal spray in children with perennial rhinitis. Br J Clin Pract 1983; 37: 259–64

    PubMed  CAS  Google Scholar 

  68. Jeal W, Faulds D. Triamcinolone acetonide: a review of its pharmacological properties and therapeutic efficacy in the management of allergic rhinitis. Drugs 1997; 53(2): 257–80

    Article  PubMed  CAS  Google Scholar 

  69. McColley SA, Carroll JL, Curtis S, et al. High prevalence of allergic sensitization in children with habitual snoring and obstructive sleep apnea. Chest 1997; 111: 170–3

    Article  PubMed  CAS  Google Scholar 

  70. McNicholas WT, Tarlo S, Cole P, et al. Obstructive apneas during sleep in patients with seasonal allergic rhinitis. Am Rev Respir Dis 1982; 126: 625–8

    PubMed  CAS  Google Scholar 

  71. Craig TJ, Teets S, Lehman EB, et al. Nasal congestion secondary to allergic rhinitis as a cause of sleep disturbance and daytime fatigue and the response to topical nasal steroids. J Allergy Clin Immunol 1998; 101: 633–7

    Article  PubMed  CAS  Google Scholar 

  72. Snyderman NL, Stool SE. Management of airway obstruction in children with infectious mononucleosis. Otolaryngol Head Neck Surg 1982; 90(2): 168–70

    PubMed  CAS  Google Scholar 

  73. Demain JG, Goetz DW. Pediatric adenoidal hypertrophy and nasal airway obstruction: reduction with aqueous nasal beclomethasone. Pediatrics 1995; 95(3): 355–64

    PubMed  CAS  Google Scholar 

  74. Al Ghamdi SA, Manoukian JJ, Morielli A, et al. Do systemic corticosteroids effectively treat obstructive sleep apnea secondary to adenotonsillar hypertrophy? Laryngoscope 1997; 107(10): 1382–7

    Article  Google Scholar 

  75. Brouillette RT, Manoukian JJ, Ducharme FM, et al. Efficacy of fluticasone nasal spray for pediatric obstructive sleep apnea. J Pediatr 2001; 138(6): 838–44

    Article  PubMed  CAS  Google Scholar 

  76. Wheeler AJ, van Someren V. Fluticasone for obstructive sleep apnea [letter]. J Pediatr 2002; 140(4): 489

    PubMed  CAS  Google Scholar 

  77. Georgalas C, Thomas K, Owens CM, et al. Medical treatment of adenoidal hypertrophy (AH) and rhinosinusitis in children: a evaluation of clinical response and changes on magnetic resonance imaging [abstract]. J Allergy Clin Immunol 2001; 107(2): A545

    Google Scholar 

  78. Marcus CL. Nasal steroids as treatment for obstructive sleep apnea: don’t throw away the scalpel yet. J Pediatr 2001; 138(6): 795–7

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

G.M. Nixon is supported by the Allan Ross Fellowship of the Department of Pediatrics, McGill University, Montreal, Canada.

Author information

Authors and Affiliations

  1. Department of Pediatrics, Montreal Children’s Hospital, 2300 rue Tupper, Montreal, Quebec, PQ H3H 1P3, Canada

    Gillian M. Nixon &  Robert T. Brouillette

Authors
  1. Gillian M. Nixon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert T. Brouillette
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robert T. Brouillette.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nixon, G.M., Brouillette, R.T. Obstructive Sleep Apnea in Children. Am J Respir Med 1, 159–166 (2002). https://doi.org/10.1007/BF03256605

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03256605

Keywords

Search

Navigation